These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24075744)

  • 1. A difference in systolic blood pressure between arms is a novel predictor of the development and progression of diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Iwase H; Kobayashi K; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2013 Oct; 230(2):198-201. PubMed ID: 24075744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A difference in systolic blood pressure between arms and between lower limbs is a novel risk marker for diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Hypertens Res; 2013 May; 36(5):403-7. PubMed ID: 23324865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Inada S; Mineoka Y; Nakanishi N; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Atherosclerosis; 2012 Jan; 220(1):155-9. PubMed ID: 22100253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes.
    Okada H; Fukui M; Tanaka M; Matsumoto S; Mineoka Y; Nakanishi N; Asano M; Yamazaki M; Hasegawa G; Nakamura N
    Diabetes Care; 2013 Jul; 36(7):1908-12. PubMed ID: 23340892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morning pulse pressure is associated more strongly with elevated albuminuria than systolic blood pressure in patients with type 2 diabetes mellitus: post hoc analysis of a cross-sectional multicenter study.
    Ushigome E; Fukui M; Hamaguchi M; Matsumoto S; Mineoka Y; Nakanishi N; Senmaru T; Yamazaki M; Hasegawa G; Nakamura N
    Diabetes Res Clin Pract; 2013 Sep; 101(3):270-7. PubMed ID: 23871575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-measured heart rate is associated with albuminuria in patients with type 2 diabetes mellitus: a post-hoc analysis of a cross-sectional multicenter study.
    Ushigome E; Fukui M; Hamaguchi M; Tanaka T; Atsuta H; Ohnishi M; Tsunoda S; Yamazaki M; Hasegawa G; Nakamura N
    Hypertens Res; 2014 Jun; 37(6):533-7. PubMed ID: 24621466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.
    Takao T; Matsuyama Y; Yanagisawa H; Kikuchi M; Kawazu S
    J Diabetes Complications; 2014; 28(2):185-90. PubMed ID: 24332763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
    Sheen YJ; Lin JL; Li TC; Bau CT; Sheu WH
    J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal home SBP targets for preventing the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Ushigome E; Hamaguchi M; Matsumoto S; Oyabu C; Omoto A; Tanaka T; Fukuda W; Hasegawa G; Mogami S; Ohnishi M; Kitagawa Y; Tsunoda S; Oda Y; Nakamura N; Fukui M
    J Hypertens; 2015 Sep; 33(9):1853-9; discussion 1859. PubMed ID: 26136206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of blood pressure level over a three years period in non-insulin dependent diabetic subjects according to their microalbuminuria].
    Mayaudon H; Bauduceau B; Ducorps M; Belmejdoub G; Poirier JM
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1045-9. PubMed ID: 8949376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate-corrected QT interval is a novel risk marker for the progression of albuminuria in people with Type 2 diabetes.
    Hashimoto Y; Tanaka M; Senmaru T; Okada H; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Nakamura N; Fukui M
    Diabet Med; 2015 Sep; 32(9):1221-6. PubMed ID: 25683576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?
    Bouchi R; Ohara N; Asakawa M; Nakano Y; Takeuchi T; Murakami M; Sasahara Y; Numasawa M; Minami I; Izumiyama H; Hashimoto K; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2016 Jan; 15():10. PubMed ID: 26790628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study.
    Oyabu C; Ushigome E; Matsumoto S; Tanaka T; Hasegawa G; Nakamura N; Ohnishi M; Tsunoda S; Ushigome H; Yokota I; Tanaka M; Asano M; Yamazaki M; Fukui M
    Diab Vasc Dis Res; 2017 Nov; 14(6):477-484. PubMed ID: 28819987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of nocturnal blood pressure in the onset of diabetic nephropathy].
    Garcia C; Mayaudon H; Bordier L; Le Berre JP; Dupuy O; Bauduceau B
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):668-72. PubMed ID: 17928773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
    Wang QY; Chen FQ
    Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.